Piñeyro G, Deveault L, de Montigny C, Blier P
Department of Psychiatry, McGill University, Montréal, Québec, Canada.
Naunyn Schmiedebergs Arch Pharmacol. 1995 Feb;351(2):119-25. doi: 10.1007/BF00169325.
Extracellular unitary recordings of dorsal hippocampus CA3 pyramidal neurons and of dorsal raphe 5-hydroxytryptamine (5-HT) neurons were used to assess the effect of tianeptine, a putative antidepressant, on the efficacy of 5-HT neurotransmission. Sustained tianeptine administration (20 mg/kg/day, s.c. x 14 days) did not modify the firing activity of 5-HT neurons in the dorsal raphe. Their responsiveness to the intravenous injection of LSD, an agonist of the somatodendritic 5-HT autoreceptor, and of 8-OH-DPAT, a selective 5-HT1A agonist, was also unaffected by this treatment. The responsiveness of CA3 pyramidal neurons to microiontophoretic application of 5-HT remained unchanged after sustained tianeptine administration, but it was markedly enhanced in rats treated with repeated electroconvulsive shocks. Finally, the duration of suppression of firing activity of CA3 pyramidal neurons produced by electrical stimulation of the ascending 5-HT pathway, delivered at 1 Hz and 5 Hz, was not modified in rats treated with tianeptine. Methiothepin, an antagonist of the terminal autoreceptor enhanced the effectiveness of 5-HT pathway stimulation to the same extent in control and tianeptine-treated rats. The present results indicate that, administered at a dose known to stimulate 5-HT reuptake (20 mg/kg/day, s.c.; by minipump), and for a period of time (14 days) for which other antidepressant treatments have been shown to enhance 5-HT function, tianeptine does not modify the efficacy of 5-HT synaptic transmission in the rat hippocampus.
采用细胞外单位记录法,记录背侧海马CA3区锥体神经元和中缝背核5-羟色胺(5-HT)能神经元的活动,以评估一种假定的抗抑郁药噻奈普汀对5-HT神经传递效能的影响。持续给予噻奈普汀(20mg/kg/天,皮下注射,共14天),并未改变中缝背核5-HT能神经元的放电活动。该处理也未影响其对静脉注射LSD(一种树突-胞体5-HT自身受体激动剂)和8-OH-DPAT(一种选择性5-HT1A激动剂)的反应性。持续给予噻奈普汀后,CA3区锥体神经元对微量离子电泳施加5-HT的反应性保持不变,但在接受重复电休克治疗的大鼠中,该反应性显著增强。最后,在1Hz和5Hz频率下电刺激上行5-HT通路所引起的CA3区锥体神经元放电活动抑制的持续时间,在接受噻奈普汀治疗的大鼠中未发生改变。终末自身受体拮抗剂甲硫噻嗪在对照组和噻奈普汀治疗组大鼠中,对5-HT通路刺激有效性的增强程度相同。目前的结果表明,以已知能刺激5-HT再摄取的剂量(20mg/kg/天,皮下注射;通过微型泵给药),并在一段其他抗抑郁治疗已被证明可增强5-HT功能的时间(14天)内给予噻奈普汀,并不会改变大鼠海马中5-HT突触传递的效能。